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Among various DNA damages, double-strand breaks (DSBs) are considered as most deleterious, as they may lead to chromosomal
rearrangements and cancer when unrepaired. Nonhomologous DNA end joining (NHEJ) is one of the major DSB repair pathways
in higher organisms. A large number of studies on NHEJ are based on in vitro systems using cell-free extracts. In this paper, we
summarize the studies on NHEJ performed by various groups in different cell-free repair systems.
1. Introduction
Maintenance of genomic integrity and stability is of prime
importance for the survival of an organism. Upon exposure
to different damaging agents, DNA acquires various lesions
such as base modifications, single-strand breaks (SSBs), and
double-strand breaks. Organisms have evolved specific repair
pathways in order to efficiently correct such DNA damages.
Examples include base excision repair (base level changes),
nucleotide excision repair (distortions in the DNA); and
single-strand break repair. DSBs are considered as the
most deleterious type of DNA damages, among different
lesions. It can result in chromosomal rearrangements like
translocations and cancer or cell death when unrepaired
[1, 2].
DSBs can be generated by pathological or physiological
agents. Pathological agents can be exogenous such as ion-
izing radiation, or chemotherapeutic agents like bleomycin
(Figure 1). They can also be endogenous like oxidative
free radicals, replication across a nick, inadvertent enzyme
action at fragile sites (Figure 1), mechanical shearing at
anaphase bridges, metabolic by products, and so forth [3–5].
Physiological processes such as V(D)J recombination, class
switch recombination (CSR); and meiosis also introduce
DSBs in our genome.
DSB repair pathways in mammals can be broadly classi-
fied into two categories, namely, homologous recombination
(HR) and nonhomologous DNA end joining. NHEJ needs
little or no homology and is usually imprecise, while HR
requires a region of extensive homology [6–8]. HR occurs in
S and G2 phases of the cell cycle and is accurate as it uses the
sister chromatid as a template to repair the damaged strand
[8–10]. The protein machinery involved in HR includes
RAD50, MRE11, NBS1, RAD51, and RAD54 [6, 11, 12]. On
the other hand, NHEJ operates throughout the cell cycle and
is error prone [4, 10, 13]. The errors introduced during NHEJ
in higher eukaryotes pose little threat to the organism as
only a small percentage of the genome encodes for proteins
whereas entering into S or G2 phase with unrepaired DNA
strands is a major risk.
2. NHEJ Proteins
Genetic studies using radiosensitive mammalian cell lines
deficient in DSB rejoining in conjunction with biochemical
evidences have led to the discovery of many NHEJ proteins.
Ku proteins, which play a major role in NHEJ, were originally
discovered as a target for autoantibodies in patients with
autoimmune diseases [14–16]. Subsequently, studies using
various DNA end structures provided the evidence that Ku
proteins recognize the DNA ends [17]. The first evidence
for the involvement of Ku proteins in NHEJ came from the
discovery that Ku80 subunit was defective in X-ray sensitive
mammalian cell mutants in the XRCC5 group [18–20]. Ku70
was identified initially as an interaction partner for Ku80 by
biochemical assays [16, 21]. Later, in vivo studies confirmed
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Figure 1: Double-strand breaks (DSBs) are generated exogenously by ionizing radiation, or endogenously by free radicals or during
V(D)J recombination in pre-B (bone marrow) and pre-T cells (thymus) by RAG complex or also during class switch recombination in
activated B cells (in the peripheral lymphoid tissues such as spleen, lymph nodes, and Peyer’s patches). NHEJ involves the binding of Ku70
and Ku80 heterodimeric complex to the DNA ends, and DNA-PKcs in association with ARTEMIS. ARTEMIS is a 5′-3′ exonuclease in
an unphosphorylated form while it is an endonuclease in a phosphorylated form. Artemis protein acts as an exonuclease and helps in
resection of the ends. Polymerase X family members are then recruited for DNA synthesis, which includes both template dependent and
independent DNA synthesis. The resulting DNA ends are ligated by a specific DNA LIGASE IV with stimulatory factors (XRCC4-LIGASE
IV-XLF complex) that restores the integrity of DNA.
this observation [22]. DNA-PKcs was first identified during
a biochemical screen for kinases that were stimulated by
double-stranded DNA [17]. Chinese hamster ovary cell
lines lacking XRCC7 showed 10-fold higher sensitivity to
radiation and later the protein coded by the gene was
identified as DNA-PK [16, 23, 24]. The critical finding
that Ku protein is the regulatory component of DNA-PKcs
unified both areas of research and gave a new dimension to
the NHEJ field. The in vivo role of Ku and DNA PKcs was
later confirmed by many studies [2, 25–29].
More or less at the same time, a distinct DNA ligase,
named DNA Ligase IV, having ATP dependent ligase activity
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was purified from HeLa cell nuclei with substrate specificity
to both single- and double-stranded breaks [30]. Later, the
same ligase was identified as the enzyme responsible for
NHEJ both in mammals and yeast [31–33]. Another, NHEJ
protein, XRCC4 was identified based on radiosensitivity
shown by mammalian cells deficient for XRCC4 gene [21,
34–36]. Later using biochemical assays it was reported
that XRCC4, small nuclear phosphoprotein, forms a tight,
specific complex with DNA Ligase IV and stimulates its
activity by many folds [32, 33]. More recently, it was
identified that an XRCC4-like protein, XLF (also known as
Cernunnos), is an interaction partner of the DNA Ligase
IV/XRCC4 complex, facilitating the ligation of the ends
[37, 38].
In early 2000, Artemis, a novel protein involved in V(D)J
recombination and DSB repair, was identified [39]. It was
reported that a mutation in the Artemis was responsible for
the SCID phenotype [39]. Later, using an elegant biochemi-
cal assay system, it was shown that phosphorylated Artemis
in conjunction with DNA-PKcs complex has the ability to
cleave the hairpin intermediate of V(D)J recombination,
besides its ability to cleave 5′-overhangs, 3′-overhangs, and
other DNA structures [40–43]. In addition, Artemis on its
own possesses an exonuclease activity [42]. Polymerases
involved inNHEJ, Pol μ and Pol λ, both belonging to the polX
family were also identified later [44, 45].
3. Mechanism of NHEJ
The key players of NHEJ recognize the broken DNA ends
and further process and ligate them [4, 6, 13, 46]. To begin
with, the DNA with DSBs is recognised by the Ku70/Ku80
heterodimeric complex, which then recruits DNA-PKcs in
association with Artemis [47–49] (Figure 1). DNA-PKcs
and Ku complex play an important role in forming a
synaptic complex that brings the two DNA ends together and
also interacts with the Ku heterodimer. DNA-PKcs further
autophosphorylates itself and phosphorylates Artemis as
well. Artemis-DNA-PKcs complex can cleave 5′-overhangs
and 3′-overhangs while Artemis alone can function as an
exonuclease [40–42]. After processing, the ends are filled
using Pol μ and Pol λ [44, 45]. Finally, the ends are
ligated by XLF:XRCC4:DNA Ligase IV complex [31, 32, 37]
(Figure 1). Since NHEJ is not precise, although the integrity
is maintained, it may lead to mutations which may further
help in evolution of the organism.
4. Alternative NHEJ
In the absence of key NHEJ proteins, a less-characterized
pathway has been shown to play an important role in
joining of DSBs, which is now classified as alternative NHEJ
or backup NHEJ or microhomology-mediated end joining
(MMEJ). Although recent studies indicate that this pathway
is distinct and error prone, the exact mechanism is yet to be
uncovered. A classic paper which introduced the term alter-
native NHEJ describes it as a possible source of chromosomal
translocation and the authors showed coamplification of
c-Myc and IgH locus from pro-B lymphomas in mice
deficient for p53 and Xrcc4 [50]. Another interesting study
showed a reduced level of class switch recombination and
increased number of chromosomal breaks at IgH locus in
mouse B cells, which were deficient for XRCC4 and Ligase IV
[51]. Another study showed the occurrence of robust alterna-
tive end joining in the absence of XRCC4 and upon removal
of certain portions of murine RAG proteins [52]. Besides,
a residual joining mediated by microhomology towards the
end of DSBs was also identified in Xrcc4 defective cells [53].
The protein machinery for this kind of backup joining in
the absence of key NHEJ proteins is still not very clear
although studies suggest the role of MRE11-RAD50-NBS1
complex in a subset of alternative NHEJ junctions [54, 55].
Another study has deciphered the role of PARP1 in repairing
switch regions through a microhomology-mediated pathway
while PARP2 suppresses IgH/c-myc translocations during
immunoglobulin class switch recombination [56]. DNA
Ligase IIIα and WRN have also been shown to contribute
to the repair of DSBs by alternative NHEJ [57]. There-
fore, canonical NHEJ requires XRCC4-Ligase IV complex
while alternative NHEJ is characterized by joining mediated
through microhomology regions, which is prominent in the
absence of canonical NHEJ proteins. Recently, an interesting
study has shown the role of XRCC4-LigaseIV in suppressing
alternative end joining during chromosomal translocations
[58]. Another study has shown the role of alternative end
joining in robust IgH locus deletions and translocations in
the combined absence of Ku70 and LigaseIV [59].
We further discuss NHEJ catalysed by crude extracts
which includes joining mediated by classical NHEJ, single-
strand annealing, alternative NHEJ, or microhomology-
mediated end joining.
5. NHEJ Assays
Since NHEJ is the major pathway of DSB repair in higher
organisms, extensive studies have been done to understand
its mechanism. Various in vitro and in vivo assays have been
designed to study NHEJ in different cell lines, which were
derived from different cancers. In this section, we will discuss
different types of NHEJ assays used in the literature, so
far. Intracellular (ex vivo) assays have been generally based
on transfection of mammalian cells with restriction enzyme
linearized plasmid DNA [60–62]. Following transfection,
cells were allowed to grow for several hours and plasmid
DNA was harvested using either alkaline lysis or a high-
salt-based nondenaturing method. The NHEJ products were
analysed by Southern hybridization. The joining junctions
were then characterized by PCR amplification followed by
cloning and sequencing. In one of the first studies, the
authors’ transfected linear SV40 genome with mismatched
ends into cultured monkey kidney cells and checked for the
presence of recombinants [60, 61, 63]. Some other studies
used vectors that overexpress I-SceI endonuclease within the
cells to induce DSBs on a plasmid containing I-SceI site,
which has an advantage that the DSBs can be induced within
the cells [64, 65].
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The intracellular assays, although widely used, havemany
shortcomings. Generally, the quantity of NHEJ products
obtained are very low and hence, various end-joined prod-
ucts such as dimer, trimer, and other forms of multimers
cannot be visualized on a gel even after Southern hybridiza-
tion. PCR amplification could be used for detecting the
NHEJ products; however, it may not be able to distinguish
between different types of joined products. Besides, while
extracting DNA out of the cell, many linear products could
be lost and hence one would not get the actual efficiency of
joining. Nevertheless, it is an excellent system because the
role of different proteins can be studied as one could generate
knockout for different NHEJ genes in cell lines.
In vitro assays, on the other hand, use a different strategy.
They use a cell-free system containing different cellular
proteins or selected purified proteins [41, 66–71]. Such
assays have been instrumental in studying NHEJ both at the
biochemical and molecular level. Cell-free system includes
either total protein, cytoplasmic, or nuclear extracts prepared
generally from cell lines or rarely from tissues [67–69, 72,
73]. Cell-free system is better because it provides greater
flexibility in selecting the types of DSB end configurations.
The sequences at or adjacent to DSBs can be easily manipu-
lated to study different junctional features of NHEJ. In vitro
assays have used two types of DNA substrates, plasmids and
oligomers. Although plasmid substrates are most commonly
used, genomic DNA has also been studied [41, 68, 73–76]
(Figure 2). DSBs are generated either by restriction enzyme
digestion, by treatment with chemicals such as bleomycin, or
by irradiation with x-rays or γ-rays [68, 73, 74, 77–79]. The
joining products can be visualised on agarose gel following
purification of products or after Southern hybridization,
depending on the quantity of the substrates used [67, 68, 73,
74]. An oligomer based system has also been used recently
for studying NHEJ [41, 76, 80]. In this assay, appropriate
oligomers can be designed, synthesized, and annealed to
generate substrates containing different DSBs (Figure 2(b)).
These substrates can be end-labelled with [γ−32P] ATP,
incubated with the extracts or purified proteins, and then
resolved on a polyacrylamide gel (Figure 2(a)). In both cases,
all the joining products can be visualised and the efficiency
of the joining between the substrates can be easily compared
as it is proportional to the intensity of bands. The standard
NHEJ products observed are dimers, trimers, multimers,
and circular products [67, 68, 74]. Similar to intracellular
studies, NHEJ junctions can be PCR amplified, cloned, and
sequenced. The extent of joining can also be determined
by using quantitative PCR [75]. Oligomeric DNA substrates
provide more flexibility with respect to end configurations of
DSBs as compared to plasmid substrates, where restriction
enzyme sites are used to generate DSBs. However, size of the
oligomers could be a limiting factor in certain studies.
6. Preparation of Cell-Free Extracts from
Different Sources
Manley et al. described the protocol for the preparation
of cell-free extracts of in vitro cultured cells for the first
time [81]. They precipitated the proteins using ammonium
sulphate following lysis of the cells using hypotonic buffer
and mechanical pressure. Later, many studies adopted mod-
ifications to Manley’s protocol to prepare cell extracts from
different sources. In one of the studies, the concentration
of ammonium sulphate was changed in order to reduce the
nonspecific nuclease activity present in the extracts [82].
Wood et al. introduced several changes to the cell extract
preparation while studying nucleotide excision repair [83].
Later, the protocol was modified to prepare cell-free extracts
from tissues (testicular cells) to study DSB repair pathways
[68, 84]. Another method of preparation of cell-free extracts
involves cellular lysis, followed by removal of cell debris
by ultracentrifugation [74]. Although both methods are
different in many ways, the overall repair efficiency of the
cell-free extracts is similar. One of the major drawbacks of
these methods is with respect to the number of cells required
for the extract preparation. Both require very high number
of cells (> 1–5 × 108). In contrast, a recent study has scaled
down the number of cells required to 5–10 × 106 [85].
The NHEJ efficiency was found to be optimum after testing
in different cell lines including MO59K (glioblastoma),
HepG2 (liver), HeLa (cervix), MCF-7 (breast), A549 (lungs),
HCT116 (colon), and RT112 (bladder). Thismicroscale assay
can be used for clinical samples and thus the role of DNA
DSB repair in tumorigenesis can be studied [85].
7. NHEJ Using Different Cell-Free Systems
Many studies have used different cell-free systems to study
NHEJ. One of the first studies to report NHEJ in vitro using
cell-free extracts was done using fertilized or activated Xeno-
pus eggs. End joining was observed using different plasmid
substrates containing DSBs with varying end configurations
[71, 86]. NHEJ has also been reported from germinal vesicles
(oocyte nuclei) of Xenopus where ligation of compatible ends
was tested and the efficiency of joining was compared among
different stages of oocyte development. Authors found that
interestingly only the stage VI oocytes showed NHEJ, which
was in presence of dNTPs. Deletions were also seen at the
junctions of the end-joined products [87].
Mammalian cells have been extensively used for in
vitro and in vivo end joining reactions. Nuclear extracts
from MRC5V1 (immortalised control fibroblasts cell line)
were found to catalyze the efficient joining of compatible
overhangs as compared to blunt ends [67, 88]. Nuclear
extracts from HeLa cells could join linear plasmid substrates,
in both head-to-head and tail-to-tail configurations [69].
Another study compared the NHEJ activity of both nuclear
and cytoplasmic extracts from three human and one mouse
cell line. Interestingly, they observed that the extent of
deletion and mechanism of joining was similar to Xenopus
oocytes [89]. A study using extracts prepared from human
lymphoblastoid cell line, GM00558B, described a precise and
LIGASE IV-dependent NHEJ on a BamHI digested plasmid
DNA. For the first time, authors showed a direct role for
Ku70, Ku80, and DNA-PKcs in NHEJ using an in vitro
cell-free system [74]. Sequence analysis of NHEJ junctions
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Figure 2: Schematic representation of NHEJ reaction using cell-free extracts. (a) Cell-free extract is incubated with one of the 5′-end-labelled
DNA substrate (oligomer) or restriction enzyme-digested plasmid DNA as shown in the figure along with NHEJ buffer. The reaction is
stopped by adding proteinase K and EDTA, DNA is purified by phenol:chloroform extraction, precipitated with glycogen and ethanol,
resuspended in TE, and run on 8% denaturing PAGE or agarose gel. After end joining, dimers, trimers, and multimers can be seen. “M” is
marker, “S” is substrate, and “P” indicates products. (b) Oligomeric or plasmid DNA substrates.
by another study showed that deletions occur exclusively
between short direct repeats in nuclear extracts prepared
from AT5BIVA (derived from ATM patient) and MRC5V1
(derived from a normal individual) [88]. SupT1 cells (human
T cell lymphoblastic lymphoma) catalyzed efficient joining
without deletions or insertions, when complementary lig-
atable ends were used for the study. However, interestingly,
even in the case of noncomplementary ends, the joining took
place without deletions [73]. Chinese hamster ovary cell line
was used to demonstrate that 125I-Triplex forming oligonu-
cleotide containing radiation-induced DSBs was repaired
at approximately 10-fold lower efficiency as compared to
restriction enzyme generated DSBs [90].
In an independent study, different cell lines were
employed while standardizing the clinical samples for
analysing NHEJ and it was observed that the efficiency of
NHEJ varied among the cells [85]. Cell-free assay was also
used to compare the efficiency of 11 sporadic breast cancer
cell lines (BCCLs) with normal fibroblasts and it was found
that only 2 BCCLs showed a reduced NHEJ in vitro [91].
Attempts were also made to study NHEJ in tissues using
cell-free extracts. In one of the first studies using a mice
testicular cell-free system, it was shown that NHEJ is efficient
in male germ cells [68, 84]. Based on plasmid rejoining assay,
the authors reported end-joining leading to dimers, trimers,
and other forms of multimers, while circularization was
absent [68]. The joining of complementary and noncom-
plementary ends took place with minimum alterations [84].
In continuation to this study, we have recently compared
the efficiency of NHEJ in mice and rat testicular extracts,
using an oligomer-based assay system. We noticed that there
was no major difference in the joining efficacy when mice
or rat testicular extracts were used (Figure 3). More recently,
we compared the NHEJ efficiencies between testis and other
somatic tissues using cell-free extracts. Interestingly, we
found that similar to testis, lungs also showed efficient NHEJ
(unpublished, SS & SCR). Efficiency of NHEJ was moderate
in case of brain, thymus, and spleen while it was weaker
in case of kidney, liver, and heart. An independent study
showed an efficient NHEJ activity in rat neurons, while it
was also shown that efficiency of NHEJ in rat neurons can go
down in an age-dependent manner [92, 93]. NHEJ activity of
nuclear extracts prepared from cortical neurons of patients
suffering from Alzheimer’s disease (AD) was also compared
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Figure 3: Comparison of efficiencies of NHEJ in rat and mice testis. Cell-free extract was prepared from age-matched rat and mice testes
and protein profile was normalized between both animals. 5 μg of protein was incubated with 4 nM of 5′-end labelled with [γ−32P] DNA
containing both compatible and blunt termini against each lane (a) which are represented schematically along with buffer containing 30mM
HEPES-KOH, pH 7.9, 7.5mM MgCl2, 1mM DTT, 2mM ATP, 50 μM dNTPs, and 0.1 μg BSA. End joining reaction using (b) compatible
end and (c) blunt end DNA. Lane 1 shows negative control that contains substrate alone, Lane 2 shows heat-inactivated control which is
mice testis cell-free extract-boiled for 10min and used for the reaction, and Lanes 3 and 4 are the end joining reactions with cell-free extract
from mice testis. Lane 5 is the heat-inactivated control which is boiled rat testicular extract as described previously. Lanes 6 and 7 are the end
joining reactions with rat testicular cell-free extracts. “M” indicates 5′-end-labelled 50 bp ladder. The efficiency of joining is similar in both
mice and rat testicular extracts. Different types of end-joined products formed are indicated.
with that of normal human subjects and it was reported
that DNA-PKcs activity was significantly lower in AD brains
when compared to healthy controls [94].
NHEJ activity was also studied in vivo by transfecting
adenovirus DNA fragments into A549 (lung carcinoma
cell line) and it was found that the joining was efficient
irrespective of the ends [72]. Previously, monkey kidney cell
lines have been used for studying NHEJ using transfection
assays [60, 61, 63, 95]. Thus, themechanistic aspects of NHEJ
have been studied using different cell lines both in vitro and
in vivo.
8. NHEJ Mechanisms in Cell-Free System
Various studies described above helped in unravelling the
mechanistic aspects of NHEJ (Figure 4). Using monkey
kidney cells transfected with SV40 T-antigen containing
episome, it was noted that single-strand extensions are stable
and few nucleotides present at the terminal end of a DSB
are important for the joining [60, 63]. The authors proposed
three independent mechanisms for the end-joining based on
the sequence at the junctions, which were single-stranded
DNA ligation, template-directed ligation, and postrepair
ligation [60]. Later, other studies helped in deciphering the
fine mechanistic details of NHEJ pathway. If the ends were
compatible, joining was predominantly conservative and
mostly required only LigaseIV or LigaseIV-XRCC4 complex
(Figure 4(a)) [68, 75]. In this case, following the alignment,
the ends were simply ligated. However, the involvement
of a separate protein for alignment is still not clear. The
joining mechanism was mostly the same for DSBs with blunt
ends as well (Figure 4(b)). In this case also, the joining
generally did not involve any modifications at the junctions,
although the efficiency was many fold lower as compared
to compatible ends. In case of noncomplementary ends
with 5′-5′ overhangs, ligation was dependent on end-filling
of one end and deletion of the other (Figure 4(c)) [96].
Alternatively, joining could occur after end-filling of each
end independently followed by ligation or joining of one
overhang with a second overhang which was end filled
(Figure 4(d)) [63]. When DSBs with 5′ and 3′ overhangs
were used for the study, a different mechanism was used,
in which single-strand ligation of protruding 5′ and 3′
ends occurred initially, followed by template dependent
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Figure 4: Schematic representation of possible mechanisms involved in repair for DNA termini. (a) In case of compatible ends, ligation
usually does not involve much modification. Here, the two termini are aligned and ligated by DNA LIGASE IV. (b) Similarly, alignment of
DNA ends in case of blunt ends take place and are ligated by DNA LIGASE IV as it does not need end modifications. On the other hand,
modifications take place for non-compatible ends. There are different possibilities in case of 5′-5′ substrate which includes (c) deletion of
nucleotides from both ends and insertion of nucleotides followed by ligation or (d) deletion of 5′-overhang from one end, end-filling of
other 5′-end followed by blunt end ligation. (e) Another possibility includes end filling of both the overhangs followed by ligation. (f) In
case of 5′-3′ overhangs, single strand ligation of overhangs is followed by template dependent synthesis and ligation. (g) Microhomology
dependent joining can take place in any of the overhangs which is characterized by pairing of microhomology region followed by removal of
flap by an endonuclease and then ligation.
strand synthesis (Figure 4(e)). In an interesting study using
Xenopus oocytes cell-extracts as a model system, a novel end
alignment mechanism, in which alignment of 3′ protruding
ends followed polymerisation and ligation of two DNA ends,
was described [86]. During joining of certain noncompatible
ends, deletion from both ends followed by blunt end ligation
has also been proposed (Figure 4(f)) [60, 71].
A microhomology-mediated joining has also been
reported by different groups irrespective of the termini
(Figure 4(g)) [84, 88, 96]. This mechanism involves exonu-
clease digestion of one of the strands till the microho-
mology region is exposed, followed by the alignment of
microhomology sequence. The flap region is deleted by
Artemis/DNAPKcs or FEN endonuclease. Template depen-
dent DNA synthesis takes place and nicks are then ligated by
using LigaseIV complex [75]. Recent studies have suggested
that in case of classical NHEJ, the microhomology box
normally consists of 1–4 nucleotides [97]. If the size of
microhomology used is more than 6–8 nucleotides, the join-
ing is categorised as an alternative NHEJ as discussed above,
which is proposed as the repair mechanism involved in the
generation of many chromosomal translocations [51, 97].
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9. Future Prospects
Numerous studies have utilized cell lines as a model system
to understand the mechanism of NHEJ. Cell lines give an
opportunity to study NHEJ at intracellular level. In addition,
cell lines grow much faster than the original tissues from
where they are derived. Therefore, it is difficult to extrapolate
these findings to the in vivo scenario, where most of the
cells of somatic tissues do not grow actively. It has been
shown that glioma cell lines possess lower DNA repair
capacity compared to the ascitic fluid collected from tumour
[98]. Moreover, studies have also shown that expression of
proteins in a cell line is different from that of the tissue of
its origin [99]. Besides, cell lines are derived from tumour
tissues and, therefore, their origin itself is controversial as
most of the tumours are metastatic [100]. Therefore, studies
using primary tissues to understand the mechanism of NHEJ
are important in the coming years.
It is known that tissues of various origins have differential
sensitivity towards radiation. It appears that there could
be a correlation between radiosensitivity and the rate of
cell division. The tissues with replicating cells, such as
blood, testis, bone marrow, ovaries, and intestine, are highly
sensitive, while others are less radiosensitive [101, 102]. γ-
H2AX formation could be correlated with radiosensitivity in
complex tissues, however, this requires more investigation.
Studies on NHEJ and the recently discovered alternative
NHEJ, at the tissue level could help in understanding the
mechanism of radiosensitivity and susceptibility to cancer in
complex tissues and organs.
Although end-alignment issues related to NHEJ have
been studied extensively, still many questions are unan-
swered. Identification of novel proteins in NHEJ may help
facilitate addressing such questions. The signalling which
follows DNA damage could be another area of interest in the
context of human diseases.
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